BELLEVUE, Wash. — Today at CannaCon 2016, Bellevue, WA-based CannaSafety LLC announced increased production and availability of their flagship product CannaRelief™, the “world’s first cannabis antidote™” and first in a family of products.
The Series A round closed quickly and was met with great enthusiasm and demand, providing the funds and support needed for initial mass production, media campaigns and new product development.
CannaRelief has been specifically formulated with ingredients that reduce anxiety and negative effects of consuming too much cannabis, and features a proprietary blend of herbs, vitamins, amino acids and CO2 extracted CBD (cannabidiol) oil from hemp seed and stalk. After more than 2 years of active development and testing, customers report that the patent-pending liquid shot takes effect in 10-15 minutes and effectively eases them back to a more comfortable level. CannaRelief works equally well in conjunction with flowers, edibles and concentrates and can be used by beginners, adventurous users and also medical patients who take CannaRelief before their high dose treatments to avoid feeling uncomfortable or anxious.
Today’s cannabis products are expertly grown and processed and can provide quite a punch to both experienced and new users, and with legal sales of cannabis in the U.S. reaching an astounding $5.4 billion in 2015. CannaRelief is poised to be the premier product in a new category of cannabis safety products. Dr. Chris Colwell, for example, chief of emergency medicine at Denver Health, recently said that they are seeing multiple cases a day involving some sort of reaction to marijuana.
Enter CannaSafety, a new company with the mission help users and patients be more proactive, responsible and safe when using cannabis. “CannaRelief contains 20mg of pure hemp CBD and is a synergistic blend of high quality ingredients that have been scientifically shown to counteract the negative effects of THC anxiety, and for about the price of a gram of cannabis, users and patients can ensure a safer and more comfortable experience,” says Dr. Erika Henry, CannaSafety Research Scientist.
Studies such as this (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055598/) from the Journal of Neuropsychopharmacology, 2009 indicate a strong anxiolytic (anti-anxiety) response from CBD in humans and animals with THC in their system, and CannaSafety is building on this research.
With a production run of 25,000 bottles recently completed at United 1 Labs in Dallas, CannaRelief is now broadly available to help users of all kinds more safely and responsibly use legal cannabis and is poised to make an impact in over-the-counter health supplements for cannabis consumers, a demographic that spans all socioeconomic groups.
“This is a total game changer,” said Bill Brouillet, COO of CannaSafety. “CannaRelief is a new tool that will substantially reduce or eliminate the number of THC anxiety related visits to the emergency room, freeing up valuable medial resources to pursue more serious incidents.”
CannaRelief is currently available in legal cannabis dispensaries and shops as well as online at www.buycannarelief.com. Having just inked a North American distribution deal with RAM 2 Holdings in Toronto, CannaSafety expects CannaRelief to be found in a wide variety of convenience stores and drug stores such as Circle K and Walgreens throughout North America as early as this spring. Learn more at www.cannasafety.com. For more information and press kits please contact email@example.com.
Food and Drug Administration (FDA) and Legal Disclosure
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program. Cannabidiol is a natural constituent of hemp oil. CannaSafety does not sell or distribute any products that are in violation of the United States Controlled Substance Act (US CSA). CannaRelief is legal in all 50 states just like the hemp lotion found at Whole Foods stores.
SOURCE CannaSafety LLC